Search

Search bills, members, committees and pages...

Sign In

2359 STRATEGIES

PreviousNext

34 federal lobbying filings, 2023 to 2025.

2359 STRATEGIES is a registrant on 34 federal lobbying filings, 2023 to 2025, reporting $150K across them.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Clients

4 who it filed for, by filings.

ClientFilingsReported
FEDERAL STREET STRATEGIES LLC10—
THE FIBROID FOUNDATION9—
TRAVERE THERAPEUTICS9$150K
DRAKE STATE COMMUNITY AND TECHNICAL COLLEGE6—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20253$12K—
202414$48K—
202317$90K—

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues18
BUDBudget/Appropriations16
COMCommunications/Broadcasting/Radio/TV9
CPIComputer Industry9
DEFDefense9
LBRLabor Issues/Antitrust/Workplace9
MEDMedical/Disease Research/Clinical Labs9
MMMMedicare/Medicaid9
PHAPharmacy9
TAXTaxation/Internal Revenue Code9
TECTelecommunications9

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1518New Era of Preventing End-Stage Kidney Disease Act1

Lobbyists

Named on the filings.

LobbyistClientsFilings
CHARLES DUJON434

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
THE FIBROID FOUNDATION2359 STRATEGIES2025 first_quarter—Apr 19, 2025
FEDERAL STREET STRATEGIES LLC2359 STRATEGIES2025 first_quarter—Apr 19, 2025
TRAVERE THERAPEUTICS2359 STRATEGIES2025 first_quarter$12KApr 19, 2025
THE FIBROID FOUNDATION2359 STRATEGIES2024 fourth_quarter—Jan 21, 2025
FEDERAL STREET STRATEGIES LLC2359 STRATEGIES2024 fourth_quarter—Jan 21, 2025
TRAVERE THERAPEUTICS2359 STRATEGIES2024 fourth_quarter$12KJan 21, 2025
THE FIBROID FOUNDATION2359 STRATEGIES2024 third_quarter—Oct 3, 2024
FEDERAL STREET STRATEGIES LLC2359 STRATEGIES2024 third_quarter—Oct 3, 2024
TRAVERE THERAPEUTICS2359 STRATEGIES2024 third_quarter$12KOct 3, 2024
THE FIBROID FOUNDATION2359 STRATEGIES2024 second_quarter—Jul 15, 2024
FEDERAL STREET STRATEGIES LLC2359 STRATEGIES2024 second_quarter—Jul 15, 2024
TRAVERE THERAPEUTICS2359 STRATEGIES2024 second_quarter$12KJul 15, 2024
FEDERAL STREET STRATEGIES LLC2359 STRATEGIES2024 first_quarter—Apr 9, 2024
THE FIBROID FOUNDATION2359 STRATEGIES2024 first_quarter—Apr 9, 2024
DRAKE STATE COMMUNITY AND TECHNICAL COLLEGE2359 STRATEGIES2024 first_quarter—Apr 9, 2024
FEDERAL STREET STRATEGIES LLC2359 STRATEGIES2024 first_quarter—Apr 9, 2024
TRAVERE THERAPEUTICS2359 STRATEGIES2024 first_quarter$12KApr 9, 2024
DRAKE STATE COMMUNITY AND TECHNICAL COLLEGE2359 STRATEGIES2023 fourth_quarter—Dec 30, 2023
THE FIBROID FOUNDATION2359 STRATEGIES2023 fourth_quarter—Dec 30, 2023
FEDERAL STREET STRATEGIES LLC2359 STRATEGIES2023 fourth_quarter—Dec 30, 2023
TRAVERE THERAPEUTICS2359 STRATEGIES2023 fourth_quarter$22.5KDec 30, 2023
DRAKE STATE COMMUNITY AND TECHNICAL COLLEGE2359 STRATEGIES2023 third_quarter—Oct 4, 2023
THE FIBROID FOUNDATION2359 STRATEGIES2023 third_quarter—Oct 4, 2023
FEDERAL STREET STRATEGIES LLC2359 STRATEGIES2023 third_quarter—Oct 4, 2023
TRAVERE THERAPEUTICS2359 STRATEGIES2023 third_quarter$22.5KOct 4, 2023